Literature DB >> 25459585

Anaphylaxis and urticaria.

Kelli W Williams1, Hemant P Sharma2.   

Abstract

Anaphylaxis and urticaria are common presenting allergic complaints. Affecting up to 2% of the population, anaphylaxis is a serious, life-threatening allergic reaction. Although not life-threatening, urticaria is a rash of transient, erythematous, pruritic wheals that can be bothersome and affects up to 25% of the population. All cases of anaphylaxis warrant thorough clinical evaluation by the allergist-immunologist, although most cases of urticaria are self-limited and do not require specialist referral. This article offers an overview of our current knowledge on the epidemiology, pathogenesis, triggers, diagnosis, and treatment of anaphylaxis and urticaria.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anaphylaxis; Prevention; Treatment; Urticaria

Mesh:

Substances:

Year:  2014        PMID: 25459585     DOI: 10.1016/j.iac.2014.09.010

Source DB:  PubMed          Journal:  Immunol Allergy Clin North Am        ISSN: 0889-8561            Impact factor:   3.479


  5 in total

1.  TOXICAN: a guide for grading dermatological adverse events of cancer treatments.

Authors:  L Peuvrel; J Cassecuel; C Bernier; G Quéreux; M Saint-Jean; M Le Moigne; C Frénard; A Khammari; B Dréno
Journal:  Support Care Cancer       Date:  2018-03-12       Impact factor: 3.603

Review 2.  Epidemiology, Mechanisms, and Diagnosis of Drug-Induced Anaphylaxis.

Authors:  Maria Isabel Montañez; Cristobalina Mayorga; Gador Bogas; Esther Barrionuevo; Ruben Fernandez-Santamaria; Angela Martin-Serrano; Jose Julio Laguna; Maria José Torres; Tahia Diana Fernandez; Inmaculada Doña
Journal:  Front Immunol       Date:  2017-05-29       Impact factor: 7.561

Review 3.  An Updated Review of the Molecular Mechanisms in Drug Hypersensitivity.

Authors:  Chun-Bing Chen; Riichiro Abe; Ren-You Pan; Chuang-Wei Wang; Shuen-Iu Hung; Yi-Giien Tsai; Wen-Hung Chung
Journal:  J Immunol Res       Date:  2018-02-13       Impact factor: 4.818

4.  Fixed drug eruption and anaphylaxis induced concurrently by erdosteine: a case report.

Authors:  Da Woon Sim; Ji Eun Yu; Young-Il Koh
Journal:  Allergy Asthma Clin Immunol       Date:  2021-02-05       Impact factor: 3.406

5.  Imidazolidinyl urea activates mast cells via MRGPRX2 to induce non-histaminergic allergy.

Authors:  Jiapan Gao; Delu Che; Xueshan Du; Yi Zheng; Huiling Jing; Nan Wang
Journal:  Toxicol Res (Camb)       Date:  2021-04-29       Impact factor: 3.524

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.